Skip to content

Clinical trials

Cognitive Dysfunction trials in China with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Not applicable Country / region: China Clear all

127 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20101
20151
20163
20178
20182
20196
202011
20215
20225
202315
202422
202519
202625

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43
Recruiting30
Unknown status28
Not yet recruiting17
Active, not recruiting3
Enrolling by invitation3
Withdrawn2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai University of Sport7
Central South University6
Second Affiliated Hospital, Zhejiang University, School of Medicine6
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School5
Beijing Tiantan Hospital4
Xuanwu Hospital, Beijing4
Beijing Anzhen Hospital3
Capital Medical University3
First Affiliated Hospital of Zhejiang University3
Lincoln University College3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction127
Alzheimer Disease16
Dementia9
Stroke9
Diabetes Mellitus, Type 28
Schizophrenia7
Bipolar Disorder4
Obesity4
Parkinson Disease4
Anxiety Disorders3

Trials

Showing 1 to 25 of 127. Each trial links to its page on Pharma Observatory.

27 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.